Article
Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.
Cancer research - 15 Dec 2000
Sigal A, Rotter V
Abstract excerpt
The p53 guardian of the genome is inactivated in the majority of cancers, mostly through missense mutations that cause single residue changes in the DNA binding core domain of the protein. Not only do such mutations result in the abrogation of wild-type p53 activity, but the expressed p53 mutant proteins also tend to gain oncogenic functions, such as interference with wild-type p53-independent apoptosis. Because...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
